Transapical Aortic Valve Implantation in High-Risk Aortic Stenosis: A Case Report

Authors

  • Abdullah Özer
  • İlker Dal
  • Okan Uğurlu
  • Mehmet Kayrak
  • Erdal Ege
  • Kurtuluş Özdemir
  • Ali Sarıgül

Abstract

 

A 72-year-old female patient with respiratory distress and chest pain was referred for echocardiography after which a severe aortic stenosis was diagnosed. From clinical perspective an AVR would have carried too much risk in this case, therefore TAVI with transapical approach via left anterior thoracotomy was the treatment of choice. In this case report, we describe our experience with this new procedure in our country.

References

Freeman RV, Otto CM. Spectrum of Calcific aortic valve disease: Pathogenesis, disease progression and treatment strategies. Circulation 2005;111:3316-26.

Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J med 1999;341:142-7.

Bonow RO, Canabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease a report of the American College of Cardiology/ American Heart Association Task Force on Pratice Guidelines ( Writing Committee to Revise the 1998 guidelines fort he management of patients with valvular heart disease) developed in collaboration with the society of Cardiovascular Anesthesiologist endorsed by the society of Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-48.

Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630-4.

Billings FT, Kodali SK, Shanewise JS. Transcatheter Aortic Valve Implatation: Anesthetic Considerations. Anesthesia- Analgesia 2009; 108:1453-62.

Andersen HR, Knudsen LL, Hasemkam JM. Transluminal implantation of artificial heart valves: Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-8.

Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002;106:3006-8.

Stewart F, SiscovickD, LindBK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol.1997;29:630-4.

Bloomstein LZ, GielchinskyI, Bernstein AD, Parsonnet V, Saunders C, Karanam R, et al. Aortic valve replacement in geriatric patients: determinants of in-hospital mortality. Ann Thorac Surg 2001;71:597-600.

Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.

Zajarias A, Criber AG, Outcomes and safety of percutaneous aortic valve replacement. J AM Coll Cardiol 2009;53:1829-36.

Downloads

Published

28.03.2016

Most read articles by the same author(s)